background image

Paid Clinical Trials El Paso

Discover 1,010 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting
PHASE3

Sponsor:

AbbVie

Location:

Denver, Aurora, Fort Collins, Lincolnshow 74 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Denver, Lakewood, Englewood, Aurorashow 395 more

Code:

NCT04181060

Conditions

Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

Stage IIIB Lung Cancer AJCC v8

Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bevacizumab

Biospecimen Collection

Computed Tomography

Echocardiography

Magnetic Resonance Imaging

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Recruiting
PHASE2

Sponsor:

Allogene Therapeutics

Location:

Denver, Kansas City, Dallas, Tylershow 27 more

Code:

NCT06500273

Conditions

Large B-cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

cemacabtagene ansegedleucel

ALLO-647

Fludarabine

Cyclophosphamide

Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Recruiting

Sponsor:

UCLA

Location:

Aurora, Salt Lake City, Oklahoma City, Dallasshow 17 more

Code:

NCT05230173

Conditions

Ulcerative Colitis

Crohn Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pragmatic

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

Recruiting
PHASE1
PHASE2

Sponsor:

Corbus Pharmaceuticals Inc.

Location:

Denver, Lincoln, Tyler, Duarteshow 11 more

Code:

NCT06265727

Conditions

Solid Tumor, Adult

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CRB-701

Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy

Recruiting

Sponsor:

BioNTech SE

Location:

Denver, Dallas, Tyler, Austinshow 13 more

Code:

NCT04813627

Conditions

Colorectal Cancer Stage II

Colorectal Cancer Stage III

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Regular blood sample collection for ctDNA assessment

A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

Recruiting
PHASE1
PHASE2

Sponsor:

Takeda

Location:

Aurora, Sioux Falls, Dallas, Minneapolisshow 7 more

Code:

NCT04844073

Conditions

Squamous Cell Cancer of Head and Neck (SCCHN)

Non-small Cell Lung Cancer (NSCLC)

Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAK-186

Abbott Ventricular Tachycardia PAS

Recruiting

Sponsor:

Abbott Medical Devices

Location:

Aurora, Salt Lake City, Oklahoma City, Overland Parkshow 10 more

Code:

NCT05839873

Conditions

Ventricular Tachycardia

Eligibility Criteria

Sex: All

Age: 7+

Healthy Volunteers: Not accepted

Interventions

FlexAbility SE Ablation Catheter

A Prospective Longitudinal Study in Adults with Multifocal Motor Neuropathy

Recruiting

Sponsor:

argenx

Location:

Aurora, Kansas City, Scottsdale, Phoenixshow 23 more

Code:

NCT05988073

Conditions

Multifocal Motor Neuropathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Recruiting
PHASE3

Sponsor:

Karyopharm Therapeutics Inc

Location:

Highlands Ranch, Salt Lake City, Sioux Falls, Oklahoma Cityshow 71 more

Code:

NCT05611931

Conditions

Endometrial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Selinexor

Matching Placebo for selinexor